Osteoporosis, the most common type of bone disease worldwide, is clinically characterized by low bone mineral density (BMD) and increased susceptibility to fracture. Multiple genetic and environmental factors and gene-environment interactions have been implicated in its pathogenesis. Osteoporosis has strong genetic determination, with the heritability of BMD estimated to be as high as 60%. More than 80 genes or genetic variants have been implicated in risk of osteoporosis by hypothesis-free genome-wide studies. However, these genes or genetic variants can only explain a small portion of BMD variation, suggesting that many other genes or genetic variants underlying osteoporosis risk await discovery. Here, we review recent progress in genome-wide studies of osteoporosis and discuss their implications for medicine and the major challenges in the field. © 2013 BioMed Central Ltd.
CITATION STYLE
Wu, S., Liu, Y., Zhang, L., Han, Y., Lin, Y., & Deng, H. W. (2013, May 29). Genome-wide approaches for identifying genetic risk factors for osteoporosis. Genome Medicine. https://doi.org/10.1186/gm448
Mendeley helps you to discover research relevant for your work.